1887
  1. الرئيسية
  2. A-Z Publications
  3. Global Cardiology Science and Practice
  4. المجلد 2014, العدد 3
  5. المقالة
Volume 2014, Issue 3
  • ISSN: 2305-7823
  • E-ISSN:

ملخص

Cardiovascular diseases are the leading cause of death worldwide. Thrombosis, the formation of blood clot (thrombus) in the circulatory system obstructing the blood flow, is one of the main causes behind various ischemic arterial syndromes such as ischemic stroke and myocardial infarction, as well as vein syndromes such as deep vein thrombosis, and consequently, pulmonary emboli. Several thrombolytic agents have been developed for treating thrombosis, the most common being tissue plasminogen activator (tPA), administrated systemically or locally via IV infusion directly proximal to the thrombus, with the aim of restoring and improving the blood flow. TPA triggers the dissolution of thrombi by inducing the conversion of plasminogen to protease plasmin followed by fibrin digestion that eventually leads to clot lysis. Although tPA provides powerful thrombolytic activity, it has many shortcomings, including poor pharmacokinetic profiles, impairment of the reestablishment of normal coronary flow, and impairment of hemostasis, leading to life-threatening bleeding consequences. The bleeding consequence is ascribed to the ability of tPA to circulate throughout the body and therefore can lysis all blood clots in the circulation system, even the good ones that prevent the bleeding and promote injury repair. This review provides an overview of the different delivery approaches for tPA including: liposomes, ultrasound-triggered thrombolysis, anti-fibrin antibody-targeted tPA, camouflaged-tPA, tpA-loaded microcarriers, and nano-modulated delivery approaches.

© 2014 El-Sherbiny, Elkholi, Yacoub, licensee Bloomsbury Qatar Foundation Journals.
Loading

جارٍ تحميل قياسات المقالة...

/content/journals/10.5339/gcsp.2014.46
٢٠١٤-١٢-٠١
٢٠٢٤-٠٧-٠٤
Loading full text...

Full text loading...

/deliver/fulltext/gcsp/2014/3/gcsp.2014.46.html?itemId=/content/journals/10.5339/gcsp.2014.46&mimeType=html&fmt=ahah

References

  1. Schussheim AE, Fuster V. Thrombosis, antithrombotic agents, and the antithrombotic approach in cardiac disease. Prog Cardiovasc Dis. 1997; 40:3:205–238.
     [Google الباحث العلمي]
  2. Abbate R, Cioni G, Ricci I, Miranda M, Gori AM. Thrombosis and acute coronary syndrome. Thromb Res. 2012; 129:3:235–240.
     [Google الباحث العلمي]
  3. Canon CP, Fuster V. Thrombogenesis, antithrombotic, and thrombolytic therapy. In: Fuster VAlexander RWO'Rourke R, eds. Hurst's The Heart. 10th ed. New York: McGraw Hill 2001;:1373–1386.
     [Google الباحث العلمي]
  4. Eisenberg PR, Ghigliotti G. Platelet-dependent and procoagulant mechanisms in arterial thrombosis. Int J Cardiol. 1999; 68:Suppl 1:S3–S10.
     [Google الباحث العلمي]
  5. Verstraete M. Biology and chemistry of thrombosis. In: Haber EBraunwald E, eds. Thrombolysis: Basic Contributions and Clinical Progress. Vol. 1. St Louis, MO: CV Mosby Year Book 1991:p.3.
     [Google الباحث العلمي]
  6. Coller BS. The role of platelets in arterial thrombosis and the rationale for blockade of platelet GPIIb/IIIa receptors as antithrombotic therapy. Eur Heart J. 1995; 16:Suppl L:11–15.
     [Google الباحث العلمي]
  7. Nguyen MC, Pride YB, Michael Gibson C. Chapter 36 Anticoagulation: Antithrombin therapy. In: Jeremias ABrown DL, eds. Cardiac Intensive Care. Philadelphia, PA: ELSEVIER 2010;:443–451.
     [Google الباحث العلمي]
  8. Colman RW, Marder VJ, Salzman EW, Hirsh J. Overview of hemostasis. In: Colman RWHirsh JMarder VJSalzman EW, eds. Hemostasis and Thrombosis; Basic Principles and Clinical Practice. 3rd ed. Philadelphia, PA: JB Lippincott 1994;:3–18.
     [Google الباحث العلمي]
  9. Kleindorfer D, Lindsell C, Brass L, Koroshetz W, Broderick J. National US estimates of recombinant tissue plasminogen activator use. Stroke. 2008; 39::924–928.
     [Google الباحث العلمي]
  10. Machado L, Sazonova I, Kozak A, Wiley D, El-Remessy A, Ergul A, Hess D, Waller J, Fagan S. Minocycline and tissue-type plasminogen activator for stroke: Assessment of interaction potential. Stroke. 2009; 40::3028–3033.
     [Google الباحث العلمي]
  11. Smith BJ. Thrombolysis in acute myocardial infarction: Analysis of studies comparing accelerated t-PA and streptokinase. J Accid Emerg Med. 1999; 16:6:407–411.
     [Google الباحث العلمي]
  12. Baruah DB, Dash RN, Chaudhari MR, Kadam SS. Plasminogen activators: A comparison. Vascul Pharmacol. 2006; 44::1–9.
     [Google الباحث العلمي]
  13. Maizel AS, Bookstein JJ. Streptokinase, urokinase, and tissue plasminogen activator: Pharmacokinetics, relative advantages, and methods for maximizing rates and consistency of lysis. Cardiovasc Intervent Radiol. 1986; 9::234–244.
     [Google الباحث العلمي]
  14. Vyas SP, Vaidya B. Targeted delivery of thrombolytic agents: Role of integrin receptors. Exp Opin Drug Deliv. 2009; 6::499–508.
     [Google الباحث العلمي]
  15. Huber K, Runge MS, Bode C, Gulba D. Thrombolytic therapy in acute myocardial infarction. Ann Hematol. 1996; 73::S29–S38.
     [Google الباحث العلمي]
  16. Stricker RB, Wong D, Shiu DT, Reyes PT, Shuman MA. Activation of plasminogen by tissue plasminogen activator on normal and thromb-asthenic platelets: Effects on surface proteins and platelet aggregation. Blood. 1986; 68::275–280.
     [Google الباحث العلمي]
  17. Vaidya B, Nayak MK, Dash D, Agrawal GP, Vyas SP. Development and characterization of site specific target sensitive liposomes for the delivery of thrombolytic agents. Int J Pharm. 2011; 403:1-2:254–261.
     [Google الباحث العلمي]
  18. Allison SD. Liposomal drug delivery. J Infus Nurs. 2007; 30:2:89–95, quiz 120.
     [Google الباحث العلمي]
  19. Huang SL. Liposomes in ultrasonic drug and gene delivery. Adv Drug Deliv Rev. 2008; 60:10:1167–1176.
     [Google الباحث العلمي]
  20. Nii T, Ishii F. Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method. Int J Pharm. 2005; 298:1:198–205.
     [Google الباحث العلمي]
  21. Psarros C, Lee R, Margaritis M, Antoniades C. Nanomedicine for the prevention, treatment and imaging of atherosclerosis. Nanomedicine. 2012; 8:Suppl 1:S59–S68.
     [Google الباحث العلمي]
  22. Torchilin VP. Targeting of drugs and drug carriers within the cardiovascular system. Adv Drug Deliv Rev. 1995; 17::75–101.
     [Google الباحث العلمي]
  23. Heeremans JL, Gerritsen HR, Meusen SP, Mijnheer FW, Gangaram Panday RS, Prevost R, Kluft C, Crommelin DJ. The preparation of tissue-type plasminogen activator (t-PA) containing liposomes: Entrapment efficiency and ultracentrifugation damage. J Drug Target. 1995; 3:4:301–310.
     [Google الباحث العلمي]
  24. Heeremans JL, Prevost R, Bekkers ME, Los P, Emeis JJ, Kluft C, Crommelin DJ. Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: A comparison with free t-PA. Thromb Haemost. 1995; 73::488–494.
     [Google الباحث العلمي]
  25. Kim JY, Kim JK, Park JS, Byun Y, Kim CK. The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator. Biomaterials. 2009; 30:29:5751–5765.
     [Google الباحث العلمي]
  26. Christian DA, Cai S, Bowen DM, Kim Y, Pajerowski JD, Discher DE. Polymersome carriers: From self-assembly to siRNA and protein therapeutics. Eur J Pharm Biopharm. 2009; 71::463–474.
     [Google الباحث العلمي]
  27. Harris JM, Chess RB. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov. 2003; 2::214–221.
     [Google الباحث العلمي]
  28. Bergstrand N. Liposomes for drug delivery: From physico-chemical studies to applications (PhD thesis) . Sweden: Uppsala University 2003.
     [Google الباحث العلمي]
  29. Nikolova AN, Jones MN. Effect of grafted PEG-2000 on the size and permeability of vesicles. Biochim Biophys Acta. 1996; 1304::120–128.
     [Google الباحث العلمي]
  30. Levchenko TS, Hartner WC, Torchilin VP, Methodist Debakey Cardiovasc J. 2012; 8:1:36–41.
     [Google الباحث العلمي]
  31. Absar S, Nahar K, Kwon YM, Ahsan F. Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy. Pharm Res. 2013; 30:6:1663–1676.
     [Google الباحث العلمي]
  32. Vaidya B, Agrawal GP, Vyas SP. Functionalized carriers for the improved delivery of plasminogen activators. Int J Pharm. 2012; 424:1-2:1–11.
     [Google الباحث العلمي]
  33. Trübestein G, Engel C, Etzel F, Sobbe A, Cremer H, Stumpff U. Thrombolysis by ultrasound. Clin Sci Mol Med. 1976; 3::697–698.
     [Google الباحث العلمي]
  34. Tachibana K, Tachibana S. Ultrasonic vibration for boosting fibrinolytic effects of urokinase in vivo. Thromb Haemost. 1981; 46::211.
     [Google الباحث العلمي]
  35. Cintas P, Le Traon AP, Larrue V. High rate of recanalization of middle cerebral artery occlusion during 2-MHz transcranial color-coded Doppler continuous monitoring without thrombolytic drug. Stroke. 2002; 33::626–628.
     [Google الباحث العلمي]
  36. Rosenschein U, Bernstein JJ, DiSegni E, Kaplinsky E, Bernheim J, Rozenzsajn LA. Experimental ultrasonic angioplasty: Disruption of atherosclerotic plaques and thrombi in vitro and arterial recanalization in vivo. J Am Coll Cardiol. 1990; 15::711–717.
     [Google الباحث العلمي]
  37. Ariani M, Fishbein MC, Chae JS, Sadeghi H, DonMichael A, Dubin SB, Siegel RJ. Dissolution of peripheral arterial thrombi by ultrasound. Circulation. 1991; 84::1680–1688.
     [Google الباحث العلمي]
  38. Uesugi Y, Kawata H, Jo J, Saito Y, Tabata Y. An ultrasound-responsive nano delivery system of tissue-type plasminogen activator for thrombolytic therapy. J Control Release. 2010; 147::269–277.
     [Google الباحث العلمي]
  39. Laing ST, Moody MR, Kim H, Smulevitz B, Huang SL, Holland CK, McPherson DD, Klegerman ME. Thrombolytic efficacy of tissue plasminogen activator-loaded echogenic liposomes in a rabbit thrombus model. Thromb Res. 2012; 130::629–635.
     [Google الباحث العلمي]
  40. Hitchcock KE, Caudell DN, Sutton,M JT, Klegerman E, Vela D, Pyne-Geithman GJ, Abruzzo T, Cyr PE, Geng YJ, McPherson DD, Holland CK. Ultrasound-enhanced delivery of targeted echogenic liposomes in a novel ex vivo mouse aorta model. J Control Release. 2010; 144::288–295.
     [Google الباحث العلمي]
  41. Francis CW. Ultrasound-enhanced thrombolysis. Echocardiography. 2001; 18:3:239–246.
     [Google الباحث العلمي]
  42. Francis CW, Blinc A, Lee S, Cox C. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol. 1995; 21::419–424.
     [Google الباحث العلمي]
  43. Siddiqi F, Blinc A, Braaten J, Francis CW. Ultrasound increases flow through fibrin gels. Thromb Haemost. 1995; 73::495–498.
     [Google الباحث العلمي]
  44. Everbach EC, Francis CW. Cavitational mechanisms in ultrasound-accelerated thrombolysis at 1 MHz. Ultrasound Med Biol. 2000; 26:7:1153–1160.
     [Google الباحث العلمي]
  45. Nyborg WL, Ziskin MC. Biological Effects of Ultrasound. NewYork: Churchill Livingstone 1985, P 1–33.
     [Google الباحث العلمي]
  46. Alexandrov AV. Ultrasound enhanced thrombolysis for stroke. Int J Stroke. 2006; 1:1:26–29.
     [Google الباحث العلمي]
  47. Rosenschein U, Frimerman A, Laniado S, Miller HI. Study of the mechanism of ultrasound angioplasty from human thrombi and bovine aorta. Am J Cardiol. 1994; 74:12:1263–1266.
     [Google الباحث العلمي]
  48. Williams AR, Chater BV, Allen KA, Sherwood MR, Sanderson JH. Release of beta-thromboglobulin from human platelets by therapeutic intensities of ultrasound. Br J Haematol. 1978; 40:1:133–142.
     [Google الباحث العلمي]
  49. Kornowski R, Meltzer RS, Chernine A, Vered Z, Battler A. Does external ultrasound accelerate thrombolysis? Results from a rabbit model. Circulation. 1994; 89:1:339–344.
     [Google الباحث العلمي]
  50. Kudo S, Furuhata H, Hara M, Maie K, Hamano K, Okamura T. Noninvasive thrombolysis with ultrasound. (abstract). Circulation. 1989; 80:suppl. I:I–345.
     [Google الباحث العلمي]
  51. Kudo S. Thrombolysis with ultrasound effect. Tokyo Jikeikai Med J. 1989; 104::1005–1012.
     [Google الباحث العلمي]
  52. Hamano K, Fujinaga T, Muto M, Yoshizawa S, Kudo S, Hara M, Okamura T, Furuhata H. Thrombolysis by transcutaneous ultrasonic irradiation. (abstract). Circulation. 1990; 82:suppl III:III–309.
     [Google الباحث العلمي]
  53. Kimura M, Iijima S, Kobayashi K, Furuhata H. Evaluation of the thrombolytic effect of tissue-type plasminogen activator with ultrasound irradiation: In vitro experiment involving assay of the fibrin degradation products from the clot. Biol Pharm Bull. 1994; 17::126–130.
     [Google الباحث العلمي]
  54. Akiyama M, Ishibashi T, Yamada T, Furuhata H. Low-frequency ultrasound penetrates the cranium and enhances thrombolysis in vitro. Neurosurgery. 1998; 43::828–832.
     [Google الباحث العلمي]
  55. Porter TR. The utilization of ultrasound and microbubbles for therapy in acute coronary syndromes. Cardiovascular Res. 2009; 83::636–642.
     [Google الباحث العلمي]
  56. Porter TR, Kricsfeld D, Lof J, Everbach EC, Xie F. Effectiveness of transcranial and transthoracic ultrasound and microbubbles in dissolving intravascular thrombi. J Ultrasound Med. 2001; 20:12:1313–1325.
     [Google الباحث العلمي]
  57. Alexandrov AV, Demchuk AM, Felberg RA, Christou I, Barber PA, Burgin WS, Malkoff M, Wojner AW, Grotta JC. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored by 2-MHz transcranial Doppler monitoring. Stroke. 2000; 31::610–614.
     [Google الباحث العلمي]
  58. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, Montaner J, Saqqur M, Demchuk AM, Moyé LA, Hill MD, Wojner AW, CLOTBUST Investigators . Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med. 2004; 351::2170–2178.
     [Google الباحث العلمي]
  59. Molina CA, Montaner J, Abilleira S, Ibarra B, Romero F, Arenillas JF, Alvarez-Sabin J. Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke. Stroke. 2001; 32::1079–1084.
     [Google الباحث العلمي]
  60. Eggers J, Koch B, Meyer K, Konig I, Seidel G. Effect of ultrasound on thrombolysis of middle cerebral artery occlusion. Ann Neurol. 2003; 53::797–800.
     [Google الباحث العلمي]
  61. Daffertshofer M, Gass A, Ringleb P, Sitzer M, Sliwka U, Els T, Sedlaczek O, Koroshetz WJ, Hennerici MG. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: Increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator. Stroke. 2005; 36::1441–1446.
     [Google الباحث العلمي]
  62. De Jong N, Ten Cate FJ. Principles and recent developments in ultrasound contrast agents. Ultrasonics. 1991; 29::324–330.
     [Google الباحث العلمي]
  63. Feinstein SB, Shah PM. Advances in contrast two-dimensional echocardiography. Cardiovasc Clin. 1986; 17::95–102.
     [Google الباحث العلمي]
  64. Burns PN. Ultrasound contrast agents in radiological diagnosis. Radiol Med (Torino). 1994; 87::71–82.
     [Google الباحث العلمي]
  65. Moehring MA, Klepper JR. Pulse Doppler ultrasound detection, characterization and size estimation of emboli in flowing blood. IEEE Trans Biomed Eng. 1994; 41::35–44.
     [Google الباحث العلمي]
  66. Becker A, Marxer E, Brüßler J, Sophia Hoormann A, Kuhnt D, Bakowsky U, Nimsky C. Ultrasound active nanoscaled lipid formulations for thrombus lysis. Eur J Pharm Biopharm. 2011; 77:3:424–429.
     [Google الباحث العلمي]
  67. Molina CA, Ribo M, Rubiera M, Montaner J, Santamarina E, Delgado-Mederos R, Arenillas JF, Huertas R, Purroy F, Delgado P, Alvarez-Sabín J. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke. 2006; 37:2:425–429.
     [Google الباحث العلمي]
  68. Dijkmans PA, Juffermans LJ, Musters RJ, van Wamel A, ten Cate FJ, van Gilst W, Visser CA, de Jong N, Kamp O. Microbubbles and ultrasound: From diagnosis to therapy. Eur J Echocardiogr. 2004; 5:4:245–256.
     [Google الباحث العلمي]
  69. Morgan KE, Allen JS, Dayton PA, Chomas JE, Klibaov AL, Ferrara KW. Experimental and theoretical evaluation of microbubble behavior: Effect of transmitted phase and bubble size. IEEE Trans Ultrason Ferroelectr Freq Control. 2000; 47:6:1494–1509.
     [Google الباحث العلمي]
  70. Alter J, Sennoga CA, Lopes DM, Eckersley RJ, Wells DJ. Microbubble stability is a major determinant of the efficiency of ultrasound and microbubble mediated in vivo gene transfer. Ultrasound Med Biol. 2009; 35:6:976–984.
     [Google الباحث العلمي]
  71. Unger EC, Porter T, Culp W, Labell R, Matsunaga T, Zutshi R. Therapeutic applications of lipid-coated microbubbles. Adv Drug Deliv Rev. 2004; 56::1291–1314.
     [Google الباحث العلمي]
  72. Sidhu PS, Allan PL, Cattin F, Cosgrove DO, Davies AH, Do DD, Karakagil S, Langholz J, Legemate DA, Martegani A, Llull JB, Pezzoli C, Spinazzi A. Diagnostic efficacy of SonoVue®, a second generation contrast agent, in the assessment of extracranial carotid or peripheral arteries using colour and spectral Doppler ultrasound: A multicentre study. Br J Radiol. 2006; 79::44–51.
     [Google الباحث العلمي]
  73. Viguier A, Petit R, Rigal M, Cintas P, Larrue V. Continuous monitoring of middle cerebral artery recanalization with transcranial color-coded sonography and Levovist. J Thromb Thrombolysis. 2005; 19::55–59.
     [Google الباحث العلمي]
  74. Alexandrov AV, Mikulik R, Ribo M, Sharma VK, Lao AY, Tsivgoulis G, Sugg RM, Barreto A, Sierzenski P, Malkoff MD, Grotta JC. A pilot randomized clinical safety study of sonothrombolysis augmentation with ultrasound-activated perflutren-lipid microspheres for acute ischemic stroke. Stroke. 2008; 39::1464–1469.
     [Google الباحث العلمي]
  75. Smith DA, Vaidya SS, Kopechek JA, Huang SL, Klegerman ME, McPherson DD, Holland CK. Ultrasound-triggered release of recombinant tissue-type plasminogen activator from echogenic liposomes. Ultrasound Med Biol. 2010; 36:1:145–157.
     [Google الباحث العلمي]
  76. Huang SL, MacDonald RC. Acoustically active liposomes for drug encapsulation and ultrasound-triggered release. Biochim Biophys Acta. 2004; 1665::134–141.
     [Google الباحث العلمي]
  77. Tiukinhoy-Laing SD, Huang S, Klegerman M, Holland CK, McPherson DD. Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes. Thromb Res. 2007; 119:6:777–784.
     [Google الباحث العلمي]
  78. Smith DAB, Porter TM, Martinez J, Huang S, MacDonald RC, McPherson DD, Holland CK. Destruction thresholds of echogenic liposomes with clinical diagnostic ultrasound. Ultrasound Med Biol. 2007; 33::797–809.
     [Google الباحث العلمي]
  79. Smith DAB, Vaidya S, Kopechek JA, Hitchcock KE, Huang SL, McPherson DD, Holland CK. Echogenic liposomes loaded with recombinant tissue-type plasminogen activator (rt-PA) for image-guided, ultrasound-triggered drug release. J Acoust Soc Am. 2007; 122::3007.
     [Google الباحث العلمي]
  80. Gore JM, Sloan M, Price TR, Young Randall AM, Bovill E, Collen D, Forman S, Knatterud GL, Sopko G, Terrin ML. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the thrombolysis in myocardial infarction study. Thrombolysis in myocardial infarction, Phase II, pilot and clinical trial. Circulation. 1991; 83::448–459.
     [Google الباحث العلمي]
  81. Shaw GJ, Meunier JM, Huang SL, Lindsell CJ, McPherson DD, Holland CK. Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes. Thromb Res. 2009; 124:3:306–310.
     [Google الباحث العلمي]
  82. Martina D, Alleiımann E, Bettinger T, Bussat P, Lassus A, Pochon S, Schneider M. Grafting of abciximab to a microbubble-based ultrasound contrast agent for targeting to platelets expressing GP IIb/IIIa—characterization and in vitro testing. Eur J Pharm Biopharm. 2008; 68::555–564.
     [Google الباحث العلمي]
  83. Mu Y, Li L, Ayoufu G. Experimental study of the preparation of targeted microbubble contrast agents carrying urokinase and RGDS. Ultrasonics. 2009; 49::676–681.
     [Google الباحث العلمي]
  84. Klegerman ME, Zou Y, Mcpherson DD. Fibrin targeting of echogenic liposomes with inactivated tissue plasminogen activator. J Liposome Res. 2008;:95–112.
     [Google الباحث العلمي]
  85. Runge MS, Bode C, Matsueda GR, Haber E. Antibody-enhanced thrombolysis: Targeting of tissue plasminogen activator in vivo. Proc Natl Acad Sci U S A. 1987; 84:21:7659–7662.
     [Google الباحث العلمي]
  86. Marsh JN, Senpan A, Hu G, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis. Nanomedicine (Lond). 2007; 2:4:533–543.
     [Google الباحث العلمي]
  87. Liang J-F, Li Y, Connell ME, Yang VC. Synthesis and characterization of positively charged tPA as a prodrug using a heparin/protamine-based drug delivery system. AAPS Pharmsci. 2000; 2:1:E7.
     [Google الباحث العلمي]
  88. Liang J-F, Li Y, Song H, Park Y-J, Naik SS, Yang VC. ATTEMPTS: A heparin/protamine-based delivery system for enzyme drugs. J Control Release. 2002; 78::67–79.
     [Google الباحث العلمي]
  89. Park Y-J, Liang J-F, Song H, Li Y, Naik SS, Yang VC. ATTEMPTS: A heparin/protamine-based triggered release system for the delivery of enzyme drugs without associated side-effects. Adv Drug Delivery Rev. 2003; 55::251–265.
     [Google الباحث العلمي]
  90. Yang VC, Naik SS, Song H, Dombkowski AA, Crippen G, Liang JF. Construction and characterization of a t-PA mutant for use in ATTEMPTS: A drug delivery system for achieving targeted thrombolysis. J Control Release. 2005; 110:1:164–176.
     [Google الباحث العلمي]
  91. Naik SS, Liang J-F, Park Y-J, Lee W-K, Yang VC. Application of ATTEMPTS for drug delivery. J Contr Rel. 2005; 10::34–45.
     [Google الباحث العلمي]
  92. Absar S, Choi S, Yang VC, Kwon YM. Heparin-triggered release of camouflaged tissue plasminogen activator for targeted thrombolysis. J Control Release. 2012; 157:1:46–54.
     [Google الباحث العلمي]
  93. Absar S, Choi S, Ahsan F, Cobos E, Yang VC, Kwon YM. Preparation and characterization of anionic oligopeptide-modified tissue plasminogen activator for triggered delivery: An approach for localized thrombolysis. Thromb Res. 2013; 131:3:e91–e99.
     [Google الباحث العلمي]
  94. Absar S, Kwon YM, Ahsan F. Bio-responsive delivery of tissue plasminogen activator for localized thrombolysis. J Control Release. 2014; 177::42–50.
     [Google الباحث العلمي]
  95. Kaminski MD, Xie Y, Mertz CJ, Finck MR, Chen H, Rosengart AJ. Encapsulation and release of plasminogen activator from biodegradable magnetic microcarriers. Eur J Pharm Sci. 2008; 35:1-2:96–103.
     [Google الباحث العلمي]
  96. Torno MD, Kaminski MD, Xie Y, Meyers RE, Mertz CJ, Liu X, O'Brien WD Jr, Rosengart AJ. Improvement of in vitro thrombolysis employing magnetically-guided microspheres. Thrombo Res. 2008; 121::799–811.
     [Google الباحث العلمي]
  97. Dobson J. Magnetic nanoparticles for drug delivery. Drug Dev Res. 2006; 67::55–60.
     [Google الباحث العلمي]
  98. Horak D, Babic M, Mackova H, Benes MJ. Preparation and properties of magnetic nano- and microsized particles for biological and environmental separations. J Sep Sci. 2007; 30:1:1751–1772.
     [Google الباحث العلمي]
  99. Chen JP, Yang PC, Ma Y-H, Wu T. Characterization of chitosan magnetic nanoparticles for in situ delivery of tissue plasminogen activator. Carbohy Polym. 2011; 84::364–372.
     [Google الباحث العلمي]
  100. Kempe M, Kempe H, Snowball I, Wallén R, Arza CR, Götberg M, Olsson T. The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy. Biomaterials. 2010; 31:36:9499–9510.
     [Google الباحث العلمي]
  101. Ma Y-H, Hsu Y-W, Chang Y-J, Hua M-Y, Chen J-P, Wu T. Intra-arterial application of magnetic nanoparticles for targeted thrombolytic therapy: A rat embolic model. J Magn Magn Mater. 2007; 311::342–346.
     [Google الباحث العلمي]
  102. Ma YH, Wu SY, Wu T, Chang YJ, Hua MY, Chen JP. Magnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticles. Biomaterials. 2009; 30:19:3343–3351.
     [Google الباحث العلمي]
  103. Lin CL, Lee CF, Chiu WY. Preparation and properties of poly(acrylic acid) oligomer stabilized superparamagnetic ferrofluid. J Colloid Interface Sci. 2005; 291:2:411–420.
     [Google الباحث العلمي]
  104. Ravi Kumar MNV. A review of chitin and chitosan applications. React Funct Polym. 2000; 46:1:1–27.
     [Google الباحث العلمي]
  105. Uesugi Y, Kawata H, Saito Y, Tabata Y. Ultrasound-responsive thrombus treatment with zinc-stabilized gelatin nano-complexes of tissue-type plasminogen activator. J Drug Target. 2012; 20:3:224–234.
     [Google الباحث العلمي]
  106. Kawata H, Uesugi Y, Soeda T, Takemoto Y, Sung JH, Umaki K, Kato K, Ogiwara K, Nogami K, Ishigami K, Horii M, Uemura S, Shima M, Tabata Y, Saito Y. A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound. J Am Coll Cardiol. 2012; 60:24:2550–2557.
     [Google الباحث العلمي]
  107. Korin N, Kanapathipillai M, Matthews BD, Crescente M, Brill A, Mammoto T, Ghosh K, Jurek S, Bencherif SA, Bhatta D, Coskun AU, Feldman CL, Wagner DD, Ingber DE. Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels. Science. 2012; 337:6095:738–742.
     [Google الباحث العلمي]
/content/journals/10.5339/gcsp.2014.46
Loading
Tissue plasminogen activator-based clot busting: Controlled delivery approaches
Global Cardiology Science and Practice 2014, 46 (٢٠١٤); https://doi.org/10.5339/gcsp.2014.46
/content/journals/10.5339/gcsp.2014.46
/content/journals/10.5339/gcsp.2014.46
Loading

جارٍ تحميل البيانات والوسائط...

  • نوع المستند: Review Article
الموضوعات الرئيسية clot busting, controlled delivery, thrombus and tissue plasminogen activator
هذه الخانة مطلوبة
يُرجى إدخال عنوان بريد إلكتروني صالح
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error